CORD-19:12d35c12218f230c49f4dc892814ba9f1037f251 / 32021-32223 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T154","span":{"begin":0,"end":202},"obj":"Sentence"}],"text":"Furthermore, these novel vaccine vectors have been increasingly used, again with varying degrees of success, in the development of therapeutic vaccines against several common cancer antigens (81, 100) ."}

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T154","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, these novel vaccine vectors have been increasingly used, again with varying degrees of success, in the development of therapeutic vaccines against several common cancer antigens (81, 100) ."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T16","span":{"begin":175,"end":181},"obj":"Phenotype"}],"attributes":[{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Furthermore, these novel vaccine vectors have been increasingly used, again with varying degrees of success, in the development of therapeutic vaccines against several common cancer antigens (81, 100) ."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T124","span":{"begin":175,"end":181},"obj":"Disease"},{"id":"T4844","span":{"begin":175,"end":181},"obj":"Disease"}],"attributes":[{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A28682","pred":"mondo_id","subj":"T4844","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Furthermore, these novel vaccine vectors have been increasingly used, again with varying degrees of success, in the development of therapeutic vaccines against several common cancer antigens (81, 100) ."}